Which of the following is a true statement about using Nitric Oxide as an alternative insufflation gas in laparoscopy?

Which of the following is a true statement about using Nitric Oxide as an alternative insufflation gas in laparoscopy?

• A. It cannot be used with suspected bowel perforation, but has no other risks.
• B. Less acid-base disturbance, improved tolerance in severe cardiopulmonary disease, and less postoperative pain.
• C. Causes significant acidosis and increases postoperative pain.
• D. It is highly flammable but has no other safety concerns.

Answer: (B)

Nitric oxide as the gas for pneumoperitoneum brings a different physiological profile than CO2, which is why the statement about its effects is the best match. CO2 used during laparoscopy tends to be absorbed into the bloodstream, raising CO2 levels and shifting the acid-base balance toward acidosis. Using NO for insufflation avoids adding CO2 load, so acid-base disturbance during and after surgery is less likely, leading to a more stable acid-base status. In patients with severe cardiopulmonary disease, NO’s effects on the vasculature can be advantageous. Its properties promote better tissue perfusion and can reduce pulmonary vascular resistance, which helps the heart and lungs cope with the physiological stresses of pneumoperitoneum. This can translate into improved tolerance of the procedure in these high-risk patients. Postoperative pain is often linked to peritoneal irritation and inflammation from the insufflation gas. Nitric oxide may mitigate some of that irritation or inflammatory response, contributing to less postoperative pain compared with CO2 pneumoperitoneum. Safety considerations are important, but the statement captures the main expected benefits: less acid-base disturbance, better tolerance in patients with cardiopulmonary disease, and reduced postoperative pain.

Nitric oxide as the gas for pneumoperitoneum brings a different physiological profile than CO2, which is why the statement about its effects is the best match. CO2 used during laparoscopy tends to be absorbed into the bloodstream, raising CO2 levels and shifting the acid-base balance toward acidosis. Using NO for insufflation avoids adding CO2 load, so acid-base disturbance during and after surgery is less likely, leading to a more stable acid-base status.

In patients with severe cardiopulmonary disease, NO’s effects on the vasculature can be advantageous. Its properties promote better tissue perfusion and can reduce pulmonary vascular resistance, which helps the heart and lungs cope with the physiological stresses of pneumoperitoneum. This can translate into improved tolerance of the procedure in these high-risk patients.

Postoperative pain is often linked to peritoneal irritation and inflammation from the insufflation gas. Nitric oxide may mitigate some of that irritation or inflammatory response, contributing to less postoperative pain compared with CO2 pneumoperitoneum.

Safety considerations are important, but the statement captures the main expected benefits: less acid-base disturbance, better tolerance in patients with cardiopulmonary disease, and reduced postoperative pain.